214 institutions reported holding $4.21B of NEWAMSTERDAM PHARMA COMPANY (NAMS) in SEC 13F filings for 2026-06-30. Largest institutional holders: Frazier Life Sciences Management, L.P. ($613.0M), Capital World Investors ($414.5M), FMR LLC ($350.4M), RA CAPITAL MANAGEMENT, L.P. ($323.7M), FCPM III SERVICES B.V. ($287.7M). Source: SEC Form 13F.
Source: SEC Form 13F filings · as of 2026-06-30